+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Ambulatory Cardiac Monitoring Devices Market Report and Forecast 2025-2034

  • PDF Icon

    Report

  • 350 Pages
  • July 2025
  • Region: Global
  • Expert Market Research
  • ID: 6163308
The global ambulatory cardiac monitoring devices market size was valued at USD 9.79 Billion in 2024, driven by the rising number of global research and development activities. The market size is anticipated to grow at a CAGR of 8.80% during the forecast period of 2025-2034 to achieve a value of USD 22.75 Billion by 2034.

Ambulatory Cardiac Monitoring Devices: Introduction

Ambulatory electrical monitors are used to record the electrical activity in the heart over a long period. These devices are wearable and convenient, allowing the patient to wear them easily. They can be worn for days, weeks, or even years. They can be used to diagnose problems that may happen unpredictably even if the patient is not under the supervision of a healthcare professional.

Ambulatory monitors can diagnose arrhythmias, which are irregular heart rhythms. Some common types of arrhythmias include bradyarrhythmias, tachyarrhythmias, supraventricular arrhythmias, and ventricular arrhythmias.

Global Ambulatory Cardiac Monitoring Devices Market Analysis

The growth of the global market for ambulatory cardiac monitoring devices is majorly driven by the rising geriatric population, which is both an opportunity and a challenge. The rising cardiovascular disorders across the globe are also driving the market growth. The rise in cardiovascular disorder cases and the increasing geriatric population are majorly contributing to the increasing demand for ambulatory cardiac monitoring devices in the market.

The increasing technological advancements are also gaining traction from healthcare professionals and facilities that are interested in providing the best services to the patient when it comes to cardiac care. Such developments are rapidly aiding the global ambulatory cardiac monitoring devices market growth. The integration of advanced technologies, such as artificial intelligence and machine learning in the healthcare sector, such as ambulatory monitoring devices, greatly influence the market growth as this integration brings clinical confidence and increases efficiency.

The increasing technological development in the market resulting from the increased number of clinical studies to improve the functionality of existing monitoring devices or developing new ones from scratch is a major trend intensifying the market growth. For example, the use of Philips MCOT (Mobile Cardiac Outpatient Telemetry) solutions, based on prescriptions, may result in less expenditure and better patient outcomes by monitoring for arrhythmic disturbances and promoting timely interventions, propelling the market growth. The introduction of smart devices with the integration of advanced technologies, such as machine learning and artificial intelligence, are also driving the growth of the global ambulatory cardiac monitoring devices market.

The increasing number of clinical trials to develop new devices and technologies for better results are also expected to drive the market growth in the coming years.

Global Ambulatory Cardiac Monitoring Devices Market Segmentations

Ambulatory Cardiac Monitoring Devices Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Market Breakup by Type

  • ECG Devices
  • Holter Monitors
  • Event Monitors
  • Implantable Loop Recorders
  • Mobile Cardiac Telemetry

Market Breakup by End User

  • Hospitals and Clinics
  • Ambulatory Care Centers
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Ambulatory Cardiac Monitoring Devices Market Overview

The growth of the global market is driven by the increasing geriatric population as older people are more susceptible to health conditions, such as high blood pressure, heart failure, diabetes, and thyroid disease, that may lead to arrhythmias. Arrhythmias caused by congenital heart defects or inherited conditions are common in children and young adults.

Key players in the market and governments are greatly investing in research and development activities associated with the development of newly advanced ambulatory cardiac monitoring devices to improve results and patient experiences, which is further driving the global ambulatory cardiac monitoring devices market growth. The presence of robust reimbursement and regulatory policies in developed and emerging economies is expected to directly contribute to the growth of the market during the forecast period. Studies say that nearly 80% of premature heart attacks and strokes are preventable if diagnosed timely. The increasing number of research and clinical studies to overcome the increasing prevalence of cardiovascular diseases and disorders are driving the market growth.

Global Ambulatory Cardiac Monitoring Devices Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Abbott
  • Boston Scientific Corporation
  • GE Healthcare
  • Cardinal Health
  • Hill-Rom Holdings
  • Koninklijke Philips N.V.
  • Medtronic
  • Nihon Kohden
  • CorporationAsahi Kasei Corporation
  • BIOTRONIK SE & Co KG
  • BPL Medical Technologies
  • iRhythm Technologies, Inc.

This product will be delivered within 3-5 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Ambulatory Cardiac Monitoring Devices Market Overview
3.1 Global Ambulatory Cardiac Monitoring Devices Market Historical Value (2018-2024)
3.2 Global Ambulatory Cardiac Monitoring Devices Market Forecast Value (2025-2034)
4 Global Ambulatory Cardiac Monitoring Devices Market Landscape
4.1 Global Ambulatory Cardiac Monitoring Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Ambulatory Cardiac Monitoring Devices Product Landscape
4.2.1 Analysis by Type
5 Global Ambulatory Cardiac Monitoring Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Ambulatory Cardiac Monitoring Devices Market Segmentation
6.1 Global Ambulatory Cardiac Monitoring Devices Market by Type
6.1.1 Market Overview
6.1.2 ECG Devices
6.1.2.1 Resting ECG Devices
6.1.2.2 Stress ECG Devices
6.1.3 Holter Monitors
6.1.4 Event Monitors
6.1.5 Implantable Loop Recorders
6.1.6 Mobile Cardiac Telemetry
6.2 Global Ambulatory Cardiac Monitoring Devices Market by End User
6.2.1 Market Overview
6.2.2 Hospitals and Clinics
6.2.3 Ambulatory Care Centers
6.2.4 Others
6.3 Global Ambulatory Cardiac Monitoring Devices Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Ambulatory Cardiac Monitoring Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Ambulatory Cardiac Monitoring Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Ambulatory Cardiac Monitoring Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Ambulatory Cardiac Monitoring Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Ambulatory Cardiac Monitoring Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Abbott
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Boston Scientific Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 GE Healthcare
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Cardinal Health
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Hill-Rom Holdings
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Koninklijke Philips N.V.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Medtronic
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Nihon Kohden Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Asahi Kasei Corporation
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 BIOTRONIK SE & Co KG
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 BPL Medical Technologies
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 iRhythm Technologies, Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
18 Global Ambulatory Cardiac Monitoring Devices Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Abbott
  • Boston Scientific Corporation
  • GE Healthcare
  • Cardinal Health
  • Financial Portfolio
  • Hill-Rom Holdings
  • Koninklijke Philips N.V.
  • Medtronic
  • Nihon Kohden Corporation
  • Asahi Kasei Corporation
  • BIOTRONIK SE & Co KG
  • BPL Medical Technologies
  • iRhythm Technologies, Inc.